Fluconazole
- Product NDC
- 16571-212
- 11-digit product format
- 165710212
- Labeler code
- 16571
- Product ID
- 16571-212_c6266a40-1ceb-4dec-adc2-a118db7cd6e5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fluconazole
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Rising Pharmaceuticals, Inc.
- Application
- ANDA076957
- Marketing category
- ANDA
- Marketing start
- 2017-03-01
- Marketing end
- 0000-00-00
- Substance
- FLUCONAZOLE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Azole Antifungal [EPC],Azoles [CS],Cytochrome P450 2C19 Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16571-212-12 | 16571021212 | 1 TABLET in 1 PACKAGE (16571-212-12) | 1 tablet | 2017-03-01 | 0000-00-00 | No | No | Current |